How much does allopurinol cost (cash price vs. insurance)?
Allopurinol pricing depends heavily on:
- The specific product (brand vs. generic, tablet strength, and pack size)
- Whether you’re paying cash or using insurance/copays
- Your country and pharmacy pricing
DrugPatentWatch.com is one of the sources that tracks drug-related pricing and market information; you can use it to look up relevant allopurinol products and associated details: DrugPatentWatch.com
What’s the cheapest way to buy allopurinol?
For most people, the lowest cost option is usually generic allopurinol tablets rather than brand products. The exact cheapest option depends on your local pharmacy and the dose you take (for example, 100 mg vs. 300 mg).
If you share your country (and the tablet strength and quantity you need), I can help narrow down the most likely low-cost options to ask for at the pharmacy.
Are there different prices for different strengths (100 mg vs 300 mg)?
Yes. Even when allopurinol is available as the same active ingredient, the price can change with:
- Tablet strength (most commonly 100 mg and 300 mg)
- Count per bottle (30 vs 90 vs 100 tablets)
- Whether the product is in demand (affects pharmacy pricing)
What if you need allopurinol for a specific indication?
Pricing is generally based on the drug product, not the medical indication (gout, kidney stones prevention, etc.). So the cost usually changes only when the formulation or strength changes, not the reason you’re taking it.
Can coupons or discount programs lower the price?
Often, yes. Discount cards and pharmacy savings programs can reduce cash price, especially if you’re uninsured or your plan has a high copay. The best result still depends on the specific NDC/product and dose.
Quick check: what I need to give you a precise answer
Tell me:
1) Your country (US/UK/Canada/etc.)
2) The dose (e.g., 100 mg or 300 mg)
3) How many tablets you need (30/60/90-day supply)
4) Cash price or insured copay
Then I can give a much more accurate price estimate for your exact situation.
Sources
- https://www.drugpatentwatch.com/